A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced ...

AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.

Alcohol can interact dangerously with common medications and supplements. Learn which combinations to avoid and how to reduce ...

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

Easy-to-digest carbs provide quick energy without upsetting your stomach. Learn which foods work best for workouts, illness, and steady fuel.

Managing your blood sugar and metabolic health is the top thing you can do to mitigate diabetes complications. Other ...

Asking your doctor questions about managing A1C, measuring blood sugar, and improving sleep can help you improve your ...

A new study published in the journal of Medicine showed that both linagliptin and dapagliflozin have good safety profiles and ...

Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

He has promised a major shake-up of the Dietary Guidelines for Americans. Here’s what experts are watching for. By Alice Callahan When Robert F. Kennedy Jr. was sworn in as health secretary last year, ...